Skip to content

Clinical trials

Phase 1 Hyperparathyroidism, Secondary trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperparathyroidism, Secondary Phase: Phase 1 Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20091
20103
20111
20142
20172
20182
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen3
KAI Pharmaceuticals2
OPKO Health, Inc.2
OPKO IP Holdings II, Inc.2
Shanghai Hengrui Pharmaceutical Co., Ltd.2
GAAD Medical Research Institute Inc.1
Kyowa Kirin Co., Ltd.1
LEO Pharma1
Vidasym, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperparathyroidism, Secondary15
Renal Insufficiency, Chronic6
Hyperparathyroidism3
Hypocalcemia2
Kidney Diseases2
Kidney Failure, Chronic2
Parathyroid Diseases2
Renal Insufficiency2
Bone Neoplasms1
Breast Neoplasms1

Trials

Showing 76 to 15 of 15. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.